(3) Using parallel reaction monitoring (PRM) targeted mass spectrometry technology to initially verify the differences of candidate protein markers in the plasma of 30 tuberculosis patients and 15 healthy people.
(3) The differences of candidate protein markers were initially verified in the plasma of 30 tuberculosis patients and 15 healthy patients using parallel reaction monitoring (PRM) targeted mass spectrometry technology.
(3) The differences of candidate protein markers in plasma of 30 patients with tuberculosis and 15 healthy subjects were preliminarily verified by parallel reaction monitoring (PRM) targeted mass spectrometry.<br>